BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24423781)

  • 1. Incident ESRD among participants in a lead surveillance program.
    Chowdhury R; Darrow L; McClellan W; Sarnat S; Steenland K
    Am J Kidney Dis; 2014 Jul; 64(1):25-31. PubMed ID: 24423781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End-stage renal disease after occupational lead exposure: 20 years of follow-up.
    Evans M; Discacciati A; Quershi AR; Åkesson A; Elinder CG
    Occup Environ Med; 2017 Jun; 74(6):396-401. PubMed ID: 27974496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival patterns of lead-exposed workers with end-stage renal disease from Adult Blood Lead Epidemiology and Surveillance program.
    Chowdhury R; Mukhopadhyay A; McClellan W; Sarnat S; Darrow L; Steenland K
    Am J Med Sci; 2015 Mar; 349(3):222-7. PubMed ID: 25504219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality among participants in a lead surveillance program.
    Chowdhury R; Sarnat SE; Darrow L; McClellan W; Steenland K
    Environ Res; 2014 Jul; 132():100-4. PubMed ID: 24769120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and end-stage renal disease incidence among dry cleaning workers.
    Calvert GM; Ruder AM; Petersen MR
    Occup Environ Med; 2011 Oct; 68(10):709-16. PubMed ID: 21172794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic renal disease among lead-exposed workers.
    Steenland K; Barry V
    Occup Environ Med; 2020 Jun; 77(6):415-417. PubMed ID: 32201386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.
    Butler AM; Olshan AF; Kshirsagar AV; Edwards JK; Nielsen ME; Wheeler SB; Brookhart MA
    Am J Kidney Dis; 2015 May; 65(5):763-72. PubMed ID: 25662835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage study of cancer risk among lead-exposed workers in New Jersey.
    Lam TV; Agovino P; Niu X; Roché L
    Sci Total Environ; 2007 Jan; 372(2-3):455-62. PubMed ID: 17129599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
    Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insight into solvent-related end-stage renal disease: occupations, products and types of solvents at risk.
    Jacob S; Héry M; Protois JC; Rossert J; Stengel B
    Occup Environ Med; 2007 Dec; 64(12):843-8. PubMed ID: 17567724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.
    Brancati FL; Whelton PK; Randall BL; Neaton JD; Stamler J; Klag MJ
    JAMA; 1997 Dec; 278(23):2069-74. PubMed ID: 9403420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational lead exposure and severe CKD: a population-based case-control and prospective observational cohort study in Sweden.
    Evans M; Fored CM; Nise G; Bellocco R; Nyrén O; Elinder CG
    Am J Kidney Dis; 2010 Mar; 55(3):497-506. PubMed ID: 20116912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
    Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
    Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorus and risk of renal failure in subjects with normal renal function.
    Sim JJ; Bhandari SK; Smith N; Chung J; Liu IL; Jacobsen SJ; Kalantar-Zadeh K
    Am J Med; 2013 Apr; 126(4):311-8. PubMed ID: 23375678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.
    Hsu CY; McCulloch CE; Darbinian J; Go AS; Iribarren C
    Arch Intern Med; 2005 Apr; 165(8):923-8. PubMed ID: 15851645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CKD stage at nephrology referral and factors influencing the risks of ESRD and death.
    Sud M; Tangri N; Levin A; Pintilie M; Levey AS; Naimark DM
    Am J Kidney Dis; 2014 Jun; 63(6):928-36. PubMed ID: 24485146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-stage renal disease among silica-exposed gold miners. A new method for assessing incidence among epidemiologic cohorts.
    Calvert GM; Steenland K; Palu S
    JAMA; 1997 Apr; 277(15):1219-23. PubMed ID: 9103346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
    Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
    Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.